Connect Biopharma Holdings Limited
CNTB
$2.05
-$0.10-4.65%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -34.90% | -29.00% | -20.79% | -20.79% | -15.93% |
| Total Receivables | -94.58% | -- | 199.43% | 199.43% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 165.60% | -- | -44.11% | -44.11% | -14.00% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -1.85% | -1.85% | -- |
| Total Current Assets | -32.91% | -- | -20.88% | -20.88% | -15.81% |
|
|
|||||
| Total Current Assets | -32.91% | -- | -20.88% | -20.88% | -15.81% |
| Net Property, Plant & Equipment | 7.90% | -- | -10.54% | -10.54% | -11.16% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -15.79% | -- | -14.52% | -14.52% | -11.63% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -53.13% | -- | 37.50% | 37.50% | -86.94% |
| Total Assets | -31.39% | -- | -20.48% | -20.48% | -16.01% |
|
|
|||||
| Total Accounts Payable | -59.76% | -- | -84.52% | -84.52% | -50.33% |
| Total Accrued Expenses | 151.20% | -- | -19.62% | -19.62% | 60.12% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 38.89% | -- | -45.96% | -45.96% | -6.91% |
| Total Finance Division Other Current Liabilities | -68.03% | -- | -96.92% | -96.92% | -55.54% |
| Total Other Current Liabilities | -68.03% | -- | -96.92% | -96.92% | -55.54% |
| Total Current Liabilities | 11.61% | -- | -66.54% | -66.54% | -35.30% |
|
|
|||||
| Total Current Liabilities | 11.61% | -- | -66.54% | -66.54% | -35.30% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 612.33% | -- | -86.67% | -86.67% | -77.29% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -69.04% | -- | 56.05% | 56.05% | 143.66% |
| Total Liabilities | 12.80% | -- | -64.77% | -64.77% | -34.29% |
|
|
|||||
| Common Stock & APIC | -29.81% | -- | 1.61% | 1.61% | 11.38% |
| Retained Earnings | 30.69% | -- | -4.74% | -4.74% | -13.84% |
| Treasury Stock & Other | -111.70% | -- | -55.39% | -55.39% | -56.59% |
| Total Common Equity | -35.42% | -18.32% | -9.19% | -9.19% | -13.82% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -35.42% | -18.32% | -9.19% | -9.19% | -13.82% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -35.42% | -18.32% | -9.19% | -9.19% | -13.82% |
|
|
|||||